Amgen Inc (AMGN)
312.67
+5.36
(+1.74%)
USD |
NASDAQ |
May 09, 13:15
Amgen Cash from Operations (Annual): 8.471B for Dec. 31, 2023
Cash from Operations (Annual) Chart
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 8.471B |
| December 31, 2022 | 9.721B |
| December 31, 2021 | 9.261B |
| December 31, 2020 | 10.50B |
| December 31, 2019 | 9.15B |
| December 31, 2018 | 11.30B |
| December 31, 2017 | 11.18B |
| December 31, 2016 | 10.35B |
| December 31, 2015 | 9.731B |
| December 31, 2014 | 8.952B |
| December 31, 2013 | 6.291B |
| December 31, 2012 | 5.882B |
| December 31, 2011 | 5.119B |
| December 31, 2010 | 5.787B |
| December 31, 2009 | 6.336B |
| December 31, 2008 | 5.988B |
| December 31, 2007 | 5.401B |
| December 31, 2006 | 5.389B |
| Date | Value |
|---|---|
| December 31, 2005 | 4.911B |
| December 31, 2004 | 3.697B |
| December 31, 2003 | 3.567B |
| December 31, 2002 | 2.249B |
| December 31, 2001 | 1.480B |
| December 31, 2000 | 1.635B |
| December 31, 1999 | 1.075B |
| December 31, 1998 | 1.042B |
| December 31, 1997 | 902.90M |
| December 31, 1996 | 822.60M |
| December 31, 1995 | 773.20M |
| December 31, 1994 | 531.90M |
| December 31, 1993 | 433.00M |
| December 31, 1992 | 292.80M |
| December 31, 1991 | 219.70M |
| March 31, 1991 | 13.50M |
| March 31, 1990 | 18.70M |
| March 31, 1989 | -5.90M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Annual) Range, Past 5 Years
8.471B
Minimum
2023
10.50B
Maximum
2020
9.42B
Average
9.261B
Median
2021
Cash from Operations (Annual) Benchmarks
| Gilead Sciences Inc | 8.006B |
| Johnson & Johnson | 22.79B |
| Eli Lilly and Co | 4.240B |
| Merck & Co Inc | 13.01B |
| Vertex Pharmaceuticals Inc | 3.537B |